RONTIS HELLAS S A has a total of 12 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and medical technology are WANG SHUMEI, GUANGXI DAQING BIOTECHNOLOGY CO LTD and SHANGHAI JIANHUA FINE BIOLOGICAL PRODUCTS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Grypioti Agni | 9 |
#2 | Barmpalexis Panagiotis | 6 |
#3 | Tsitsas Panagiotis | 3 |
#4 | Moulas Anargyros | 3 |
Publication | Filing date | Title |
---|---|---|
CA3094551A1 | Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof | |
WO2019011393A1 | Extended release pharmaceutical composition containing fesoterodine and process for the preparation thereof | |
US2017246354A1 | Drug eluting device | |
EP3377046A1 | Pharmaceutical composition containing a non-steroidal antiinflammatory drug and a proton pump inhibitor | |
WO2017080566A1 | Stable analgesic pharmaceutical composition and process for the preparation thereof | |
WO2017059877A1 | Pharmaceutical composition containing agomelatine and process for the preparation thereof | |
WO2016086950A1 | Pharmaceutical composition containing non-lipophilic hydrophobic drug and process for the preparation thereof |